NCT03604783: Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors |
|
|
| Terminated | 1 | 74 | US | TP-1287 | Sumitomo Pharma America, Inc. | Advanced Solid Tumors, Sarcoma, Ewing Sarcoma, Dedifferentiated Liposarcoma, Synovial Sarcoma | 01/24 | 01/24 | | |
